Overall rank by patents
#1,330
Across all tracked assignees
USPTO PatentsView assignee record - 319 granted patents across 113 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A24B (MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF).
The verdict
R.j. holds 319 US patents across 113 technology areas, rank #1,330 of 50,000 tracked assignees.
R.j. Reynolds Tobacco Company has been granted 319 US utility patents between 2015 and 2025, placing R.j. Reynolds Tobacco Company at rank #1,330 across all assignees tracked by PlainPatent. This portfolio spans 113 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.6 claims per patent with primary concentration in A24B (MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF). As a US Corporation, R.j. Reynolds Tobacco Company is one of the broader-portfolio assignees in the PatentsView dataset. By volume, R.j. sits between Sandia Corporation (320 patents, rank #1,326) and Massachusetts Mutual Life Insurance Company (317 patents, rank #1,334) - the closest US assignees by grant volume. The composite Innovation Score of 61.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 146 grants, compared with 173 in the 2015–2019 window, a -16% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. R.j. Reynolds Tobacco Company's 18.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a diversified footprint across 100+ CPC subclasses spreads risk across many technology fronts. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark R.j. Reynolds Tobacco Company against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Sandia Corporation
320 patents
Amkor Technology, Inc.
319 patents
ITRON, INC.
319 patents
Kiekert AG
319 patents
THE CHEMOURS COMPANY FC, LLC
319 patents
R.J. REYNOLDS TOBACCO COMPANY
319 patents
Genzyme Corporation
317 patents
HARMAN BECKER AUTOMOTIVE SYSTEMS GMBH
317 patents
Massachusetts Mutual Life Insurance Company
317 patents
What this shows R.j. holds 319 patents at rank #1,330, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #1,330 in granted patent volume.
Other assignees with the most granted patents in Rj's primary technology class.
R.j.'s Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
62 Top 3% higher than 97% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 43 | 13.5% |
| 2016 | 37 | 11.6% |
| 2017 | 25 | 7.8% |
| 2018 | 34 | 10.7% |
| 2019 | 34 | 10.7% |
| 2020 | 29 | 9.1% |
| 2021 | 27 | 8.5% |
| 2022 | 24 | 7.5% |
| 2023 | 25 | 7.8% |
| 2024 | 25 | 7.8% |
| 2025 | 16 | 5.0% |
Top 15 of 113 technology areas
Overall rank by patents
#1,330
Across all tracked assignees
61.6 out of 100
How to use this portfolio
R.j.'s 319 grants land it in the top 3% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.